BMS-863233 (XL-413)|cas 1169562-71-3| DC Chem|Supplier|Price|Buy  

BMS-863233 (XL-413)|cas 1169562-71-3| DC Chem|Supplier|Price|Buy

DC Chemicals Supply: BMS-863233 (XL-413)|cas 1169562-71-3,Purity: >98% ,Cat No. DC7090, In stock.

Contact: website: www.dcchemicals.com,

sales@dcchemicals.com,order@dcchemicals.com,info@dcchemicals.com,

Tel: +86-21-61454686;Fax:+86-21-61642559；

BMS-863233 (XL-413)|cas 1169562-71-3 ,Synonym: BMS-863233; BMS863233; BMS 863233; XL-413; XL413; XL 413. ,Chemical name: (S)-8-chloro-2-(pyrrolidin-2-yl)benzofuro[3,2-d]pyrimidin-4(3H)-one  hydrochloride ,Molecular Formula: C14H13Cl2N3O2 ,MW:326.17792

BMS-863233 (XL-413), cas 1169562-71-3,Purity: >98%, Best Price and quality from DC Chemicals. BMS-863233, also known as XL-413,  is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. CDC7 kinase inhibitor BMS-863233 binds to and inhibits the activity of CDC7, which may result in the inhibition of DNA replication and mitosis, the induction of tumor cell apoptosis, and the inhibition of tumor cell proliferation in CDC7-overexpressing tumor cells. CDC7, a serine-threonine kinase overexpressed in a variety of tumor cell types, plays an essential role in the initiation of DNA replication by activating origins of replication. 

BMS-863233, also known as XL-413,  is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. CDC7 kinase inhibitor BMS-863233 binds to and inhibits the activity of CDC7, which may result in the inhibition of DNA replication and mitosis, the induction of tumor cell apoptosis, and the inhibition of tumor cell proliferation in CDC7-overexpressing tumor cells. CDC7, a serine-threonine kinase overexpressed in a variety of tumor cell types, plays an essential role in the initiation of DNA replication by activating origins of replication.